Relation Therapeutics discovers and develops medicines by combining patient-derived biological data, machine learning, and laboratory experiments to identify and validate disease targets.

Products & media

Relation Discovery Platform

A partnered drug-discovery platform combining patient-derived multi-omic data, machine learning and experimental validation.

Relation Development Platform

A platform for connecting biological understanding with the development of therapeutic programs.

MORGAN

Announced cellular foundation models for partnered drug discovery, using multi-omic perturbation data to predict responses to genetic and therapeutic interventions.

Cosigns

Jason PontinGeneral Partner at DCVC investing in deep technology; former editor in chief and publisher of MIT Technology Review.
“Relation brings a powerful, proven approach to interrogating extremely complex information to efficiently make high-quality recommendations.”
Source

Team

2 people across company lists

Jobs

Funding

All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.

Data current as of December 9, 2025

Leads

Participating Firms

Angels

Strategic equity investment

Undisclosed amount